WallStreetZenWallStreetZen

NASDAQ: BIOX
Bioceres Crop Solutions Corp Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

BIOX past earnings growth

How has BIOX's earnings growth performed historically?
Company
N/A
Industry
-43.66%
Market
61.16%
BIOX's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
BIOX's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance

BIOX past revenue growth

How has BIOX's revenue growth performed historically?
Company
13.94%
Industry
-17.42%
Market
16.96%
BIOX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BIOX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BIOX's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BIOX earnings and revenue history

Current Revenue
$450.3M
Current Earnings
$22.0M
Current Profit Margin
4.9%

BIOX Return on Equity

Current Company
7.3%
Current Industry
10.3%
Current Market
188%
BIOX's Return on Equity (7.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BIOX announces earnings.

BIOX Return on Assets

Current Company
2.7%
Current Industry
4.1%
BIOX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BIOX Return on Capital Employed

Current Company
11.1%
Current Industry
6.8%
BIOX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BIOX vs Agricultural Input Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BIOX$450.32M$74.96M$21.96M+25.51%+95.10%
UAN$681.48M$281.10M$172.43M+14.18%+49.37%
LVRO$1.88B$74.05M-$111.65M+138.53%N/A
AVD$579.37M$44.97M$7.52M+4.99%-20.12%
IPI$279.08M-$4.66M-$35.67M+6.03%N/A
View Top Agricultural Input Stocks

BIOX earnings dates

Next earnings date
May 8, 2024

Bioceres Crop Solutions Earnings & Revenue FAQ

What were BIOX's earnings last quarter?

On Invalid Date, Bioceres Crop Solutions (NASDAQ: BIOX) reported Q4 2023 earnings per share (EPS) of $0.00, up 101.52% year over year. Total Bioceres Crop Solutions earnings for the quarter were $108.45 thousand. In the same quarter last year, Bioceres Crop Solutions's earnings per share (EPS) was -$0.13.

If you're new to stock investing, here's how to buy Bioceres Crop Solutions stock.

What was BIOX's earnings growth in the past year?

As of Q2 2024, Bioceres Crop Solutions's earnings has grown year over year. Bioceres Crop Solutions's earnings in the past year totalled $21.96 million.

What is BIOX's earnings date?

Bioceres Crop Solutions's earnings date is Invalid Date. Add BIOX to your watchlist to be reminded of BIOX's next earnings announcement.

What was BIOX's revenue last quarter?

On Invalid Date, Bioceres Crop Solutions (NASDAQ: BIOX) reported Q4 2023 revenue of $139.47 million up 50.13% year over year. In the same quarter last year, Bioceres Crop Solutions's revenue was $92.90 million.

What was BIOX's revenue growth in the past year?

As of Q2 2024, Bioceres Crop Solutions's revenue has grown 13.94% year over year. This is 31.35 percentage points higher than the US Agricultural Inputs industry revenue growth rate of -17.42%. Bioceres Crop Solutions's revenue in the past year totalled $450.32 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.